Retained role of surgery for olfactory neuroblastoma
Corresponding Author
Robert I. Smee FRANZCR
Department of Radiation Oncology, The Prince of Wales Cancer Centre, Randwick, New South Wales, Australia
Department of Radiation Oncology, The Prince of Wales Cancer Centre, Randwick, New South Wales, AustraliaSearch for more papers by this authorKathryn Broadley
Department of Radiation Oncology, The Prince of Wales Cancer Centre, Randwick, New South Wales, Australia
Search for more papers by this authorJanet R. Williams SRN
Department of Radiation Oncology, The Prince of Wales Cancer Centre, Randwick, New South Wales, Australia
Search for more papers by this authorNicola S. Meagher MPH
Integrated Cancer Research, UNSW Cancer Research Centre Faculty of Medicine, University of New South Wales, Randwick, New South Wales, Australia
Search for more papers by this authorG. Patrick Bridger FRACS, MD
Department of Otolaryngology, The Prince of Wales Cancer Centre, Randwick, New South Wales, Australia
Search for more papers by this authorCorresponding Author
Robert I. Smee FRANZCR
Department of Radiation Oncology, The Prince of Wales Cancer Centre, Randwick, New South Wales, Australia
Department of Radiation Oncology, The Prince of Wales Cancer Centre, Randwick, New South Wales, AustraliaSearch for more papers by this authorKathryn Broadley
Department of Radiation Oncology, The Prince of Wales Cancer Centre, Randwick, New South Wales, Australia
Search for more papers by this authorJanet R. Williams SRN
Department of Radiation Oncology, The Prince of Wales Cancer Centre, Randwick, New South Wales, Australia
Search for more papers by this authorNicola S. Meagher MPH
Integrated Cancer Research, UNSW Cancer Research Centre Faculty of Medicine, University of New South Wales, Randwick, New South Wales, Australia
Search for more papers by this authorG. Patrick Bridger FRACS, MD
Department of Otolaryngology, The Prince of Wales Cancer Centre, Randwick, New South Wales, Australia
Search for more papers by this authorAbstract
Background
Olfactory neuroblastoma is a rare paranasal sinus malignancy. The traditional approach was craniofacial resection (CFR) and then postoperative radiotherapy until 1998. This review will chart development of a new protocol.
Methods
This ethics-approved audit evaluated the number of new patients diagnosed with olfactory neuroblastoma, with information relating to patient, disease, and treatment factors noted.
Results
There were 24 eligible patients, 16 men, 8 women, 7 Kadish stage B, 17 stage C. The planned treatment was: chemotherapy (cisplatin/etoposide) and determine treatment dependent on response in 6 patients, surgery and radiotherapy in 16 patients, and single-modality treatment only (surgery, radiotherapy 1) in 2 patients. Surgery to radiotherapy occurred in 17 patients. With salvage treatment ultimate local control was 79%.
Conclusions
There was a higher local control in those patients who had surgery; abandoning this may carry a higher risk of local failure. The use of response to chemotherapy to determine local treatment remains experimental. © 2010 Wiley Periodicals, Inc. Head Neck, 2010
REFERENCES
- 1 Dulguerov P, Allal AS, Calcaterra TC. Esthesioneuroblastoma: a meta-analysis and review. Lancet Oncol 2001; 2: 683–690.
- 2 Harnsberger HR, Wiggins RHIII, Hudgins PA, et al. Esthesioneuroblastoma. In: Diagnostic imaging: head and neck. Salt Lake City, UT: Amirsys; 2004. pp 86–89.
- 3 Lund VJ, Howard D, Wei W, Spittle M. Olfactory neuroblastoma: past, present, and future? Laryngoscope 2003; 113: 502–507.
- 4
Skarsgard DP,
Groome PA,
MacKillop WJ, et al.
Cancers of the upper aerodigestive tract in Ontario, Canada, and the United States.
Cancer
2000;
88:
1728–1738.
10.1002/(SICI)1097-0142(20000401)88:7<1728::AID-CNCR29>3.0.CO;2-7 CAS PubMed Web of Science® Google Scholar
- 5 Theilgaard SA, Buchwald C, Ingeholm P, Kornum Larsen S, Eriksen JG, Sand Hansen H. Esthesioneuroblastoma: a Danish demographic study of 40 patients registered between 1978 and 2000. Acta Otolaryngol 2003; 123: 433–439.
- 6 Morita A, Ebersold MJ, Olsen KD, Foote RL, Lewis JE, Quast LM. Esthesioneuroblastoma: prognosis and management. Neurosurgery 1993; 32: 706–715.
- 7 Oskouian RJ Jr, Jane JA Sr, Dumont AS, Sheehan JM, Laurent JJ, Levine PA. Esthesioneuroblastoma: clinical presentation, radiological, and pathological features, treatment, review of the literature, and the University of Virginia experience. Neurosurg Focus 2002; 12: e4 (abstract).
- 8 Spaulding CA, Kranyak MS, Constable WC, Stewart FM. Esthesioneuroblastoma: a comparison of two treatment eras. Int J Radiat Oncol Biol Phys 1988; 15: 581–590.
- 9 Rankin S. Paranasal sinus neoplasms. In: RR Husband JE, editor. Imaging in oncology. London: Taylor & Francis; 2004. p 588.
- 10
Kadish S,
Goodman M,
Wang CC.
Olfactory neuroblastoma. A clinical analysis of 17 cases.
Cancer
1976;
37:
1571–1576.
10.1002/1097-0142(197603)37:3<1571::AID-CNCR2820370347>3.0.CO;2-L CAS PubMed Web of Science® Google Scholar
- 11 Koka VN, Julieron M, Bourhis J, et al. Aesthesioneuroblastoma. J Laryngol Otol 1998; 112: 628–633.
- 12
Kleihues P,
Burger PC,
Scheithauer BW.
Tumors of neuroepithelial tissue. In:
World Health Organisation international histological classification of tumors: histological typing of tumors of the central nervous system.
Berlin:
Springer-Verlag;
1993. pp
25–26.
10.1007/978-3-642-84988-6 Google Scholar
- 13 Hyams V. Olfactory neuroblastoma. In: VJ Hyams, JG Baksakis, L Michaels, editors. Tumors of the upper respiratory tract and ear. Washington DC: Armed Forces Institute of Pathology; 1988. pp 240–248.
- 14 Biller HF, Lawson W, Sachdev VP, Som P. Esthesioneuroblastoma: surgical treatment without radiation. Laryngoscope 1990; 100: 1199–1201.
- 15
Eden BV,
Debo RF,
Larner JM, et al.
Esthesioneuroblastoma. Long-term outcome and patterns of failure—the University of Virginia experience.
Cancer
1994;
73:
2556–2562.
10.1002/1097-0142(19940515)73:10<2556::AID-CNCR2820731017>3.0.CO;2-S CAS PubMed Web of Science® Google Scholar
- 16 Eich HT, Muller R-P, Micke O, Kocher M, Berthold F, Hero B. Esthesioneuroblastoma in childhood and adolescence. Better prognosis with multimodal treatment? Strahlenther Onkol 2005; 181: 378–384.
- 17 Irish J, Dasgupta R, Freeman J, et al. Outcome and analysis of the surgical management of esthesioneuroblastoma. J Otolaryngol 1997; 26: 1–7.
- 18 McLean JN, Nunley SR, Klass C, Moore C, Muller S, Johnstone PAS. Combined modality therapy of esthesioneuroblastoma. Otolaryngol Head Neck Surg 2007; 136: 998–1002.
- 19 Rice DH, Stanley RB Jr. Surgical therapy of tumors of the nasal cavity, ethmoid sinus, and maxillary sinus. In: SE Thawley, WR Panje, JG Batsakis, et al, editors. Comprehensive management of head and neck tumors, 2nd edition. Philadelphia, PA: WB Saunders; 1999. pp 558–581.
- 20 Loy AH, Reibel JF, Read PW, et al. Esthesioneuroblastoma: continued follow-up of a single institution's experience. Arch Otolaryngol Head Neck Surg 2006; 132: 134–138.
- 21 Eriksen JG, Bastholt L, Krogdahl AS, Hansen O, Joergensen KE. Esthesioneuroblastoma—what is the optimal treatment? Acta Oncol 2000; 39: 231–235.
- 22 Polin RS, Sheehan JP, Chenelle AG, et al. The role of preoperative adjuvant treatment in the management of esthesioneuroblastoma: the University of Virginia experience. Neurosurgery 1998; 42: 1029–1037.
- 23 Perez CA, Thorstad, WL. Unusual nonepithelial tumors of the head and neck. In: E Halperin, C Perez, L Brady, editors. Perez and Brady's principles and practice of radiation oncology. Philadelphia: Wolters Kluwer/Lippincott Williams & Wilkins; 2008. pp 1012–1019.
- 24 Chao KS, Kaplan C, Simpson JR, et al. Esthesioneuroblastoma: the impact of treatment modality. Head Neck 2001; 23: 749–757.
- 25 Porter A, Bernold D, Giannini C, et al. Retrospective review of adjuvant chemotherapy for esthesioneuroblastoma. J Neuro-Oncol 2008; 90: 201–204.
- 26 Roux FX, Brasnu D, Villavicencio R, Menard M, Bassot V, Devaux B. Esthesioneuroblastomas. Could a preoperative chemotherapy improve their prognosis? Neuro-Chirurgie 1991; 37: 248–252.
- 27 Foote RL, Morita A, Ebersold MJ, et al. Esthesioneuroblastoma: the role of adjuvant radiation therapy. Int J Radiat Oncol Biol Phys 1993; 27: 835–842.
- 28 Unger F, Walch C, Stammberger H, Papaefthymiou G, Haselsberger K, Pendl G. Olfactory neuroblastoma (esthesioneuroblastoma): report of six cases treated by a novel combination of endoscopic surgery and radiosurgery. Minim Invasive Neurosurg 2001; 44: 79–84.
- 29 Walch C, Stammberger H, Anderhuber W, Unger F, Kole W, Feichtinger K. The minimally invasive approach to olfactory neuroblastoma: combined endoscopic and stereotactic treatment. Laryngoscope 2000; 110: 635–640.
- 30 Castelnuovo P, Bignami M, Delu G, Battaglia P, Bignardi M, Dallan I. Endonasal endoscopic resection and radiotherapy in olfactory neuroblastoma: our experience. Head Neck 2007; 29: 845–850.
- 31 Devaiah AK, Larsen C, Tawfik O, O'Boynick P, Hoover LA. Esthesioneuroblastoma: endoscopic nasal and anterior craniotomy resection. Laryngoscope 2003; 113: 2086–2090.
- 32 Suriano M, De Vincentiis M, Colli A, Benfari G, Mascelli A, Gallo A. Endoscopic treatment of esthesioneuroblastoma: a minimally invasive approach combined with radiation therapy. Otolaryngol Head Neck Surg 2007; 136: 104–107.
- 33 Bhattacharyya N, Thornton AF, Joseph MP, Goodman ML, Amrein PC. Successful treatment of esthesioneuroblastoma and neuroendocrine carcinoma with combined chemotherapy and proton radiation. Results in 9 cases. Arch Otolaryngol Head Neck Surg 1997; 123: 34–40.
- 34 Constantinidis J, Steinhart H, Koch M, et al. Olfactory neuroblastoma: the University of Erlangen-Nuremberg experience 1975–2000. Otolaryngol Head Neck Surg 2004; 130: 567–574.
- 35 Beitler JJ, Fass DE, Brenner HA, et al. Esthesioneuroblastoma: is there a role for elective neck treatment? Head Neck 1991; 13: 321–326.
- 36 Rinaldo A, Ferlito A, Shaha AR, Wei WI, Lund VJ. Esthesioneuroblastoma and cervical lymph node metastases: clinical and therapeutic implications. Acta Oto-Laryngol 2002; 122: 215–221.
- 37 Eich HT, Staar S, Micke O, Eich PD, Stutzer H, Muller R. Radiotherapy of esthesioneuroblastoma. Int J Radiat Oncol Biol Phys 2001; 49: 155–160.
- 38 Diaz EM Jr, Johnigan RHIII, Pero C, et al. Olfactory neuroblastoma: the 22-year experience at one comprehensive cancer center. Head Neck 2005; 27: 138–149.
- 39 Levine PA, Gallagher R, Cantrell RW. Esthesioneuroblastoma: reflections of a 21-year experience. Laryngoscope 1999; 109: 1539–1543.
- 40 Benfari G, Fusconi M, Ciofalo A, et al. Radiotherapy alone for local tumour control in esthesioneuroblastoma. Acta Otorhinolaryngol Ital 2008; 28: 292–297.
- 41 Devaiah AK, Andreoli MT. Treatment of esthesioneuroblastoma: a 16-year meta-analysis of 361 patients. Laryngoscope 2009; 119: 1412–1416.
- 42 Zafereo ME, Fakhri S, Prayson R, et al. Esthesioneuroblastoma: 25-year experience at a single institution. Otolaryngol Head Neck Surg 2008; 138: 452–458.
- 43 Bachar G, Goldstein DP, Shah M, et al. Esthesioneuroblastoma: the Princess Margaret Hospital experience. Head Neck 2008; 30: 1607–1614.
- 44 Kim HJ, Kim CH, Lee BJ, et al. Surgical treatment versus concurrent chemoradiotherapy as an initial treatment modality in advanced olfactory neuroblastoma. Auris Nasus Larynx 2007; 34: 493–498.
- 45 Bragg TMF, Muzaffar K. Clinicopathological review: esthesioneuroblastoma. Neurosurgery 2009; 64: 764–770.
Citing Literature
